Abstract
Gemtuzumab ozogamicin in AML: the next chapter
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.2023022244
Journal: Blood | Publication Date: Nov 16, 2023 |
Citations: 2 |
Gemtuzumab ozogamicin in AML: the next chapter
Join us for a 30 min session where you can share your feedback and ask us any queries you have